The global Motion Sickness Durg market is projected to grow from US$ 502 million in 2024 to US$ 606.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period.

Motion Sickness Durg Market

Motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Motion Sickness Durg, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Motion Sickness Durg, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Motion Sickness Durg, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Motion Sickness Durg sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Motion Sickness Durg market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Motion Sickness Durg sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Motion Sickness Durg Market Report

Report Metric	Details
Report Name	Motion Sickness Durg Market
Accounted market size in 2024	US$ 502 million
Forecasted market size in 2030	US$ 606.4 million
CAGR	3.2
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Anticholinergic Antihistamines Others
Segment by Application	Adults Children
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	WellSpring Pharmaceutical Corporation, Baxter International, Mylan, Novartis, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Motion Sickness Durg in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Motion Sickness Durg manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Motion Sickness Durg sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Motion Sickness Durg Market growing?

Ans: The Motion Sickness Durg Market witnessing a CAGR of 3.2 during the forecast period 2025-2030.

What is the Motion Sickness Durg Market size in 2030?

Ans: The Motion Sickness Durg Market size in 2030 will be US$ 606.4 million.

Who are the main players in the Motion Sickness Durg Market report?

Ans: The main players in the Motion Sickness Durg Market are WellSpring Pharmaceutical Corporation, Baxter International, Mylan, Novartis, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals

What are the Application segmentation covered in the Motion Sickness Durg Market report?

Ans: The Applications covered in the Motion Sickness Durg Market report are Adults, Children

What are the Type segmentation covered in the Motion Sickness Durg Market report?

Ans: The Types covered in the Motion Sickness Durg Market report are Anticholinergic, Antihistamines, Others

1 Study Coverage

1.1 Motion Sickness Durg Product Introduction

1.2 Market by Type

1.2.1 Global Motion Sickness Durg Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Anticholinergic

1.2.3 Antihistamines

1.2.4 Others

1.3 Market by Application

1.3.1 Global Motion Sickness Durg Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Adults

1.3.3 Children

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Motion Sickness Durg Sales Estimates and Forecasts 2019-2030

2.2 Global Motion Sickness Durg Revenue by Region

2.2.1 Global Motion Sickness Durg Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Motion Sickness Durg Revenue by Region (2019-2024)

2.2.3 Global Motion Sickness Durg Revenue by Region (2025-2030)

2.2.4 Global Motion Sickness Durg Revenue Market Share by Region (2019-2030)

2.3 Global Motion Sickness Durg Sales Estimates and Forecasts 2019-2030

2.4 Global Motion Sickness Durg Sales by Region

2.4.1 Global Motion Sickness Durg Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Motion Sickness Durg Sales by Region (2019-2024)

2.4.3 Global Motion Sickness Durg Sales by Region (2025-2030)

2.4.4 Global Motion Sickness Durg Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Motion Sickness Durg Sales by Manufacturers

3.1.1 Global Motion Sickness Durg Sales by Manufacturers (2019-2024)

3.1.2 Global Motion Sickness Durg Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Motion Sickness Durg in 2023

3.2 Global Motion Sickness Durg Revenue by Manufacturers

3.2.1 Global Motion Sickness Durg Revenue by Manufacturers (2019-2024)

3.2.2 Global Motion Sickness Durg Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Motion Sickness Durg Revenue in 2023

3.3 Global Key Players of Motion Sickness Durg, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Motion Sickness Durg Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Motion Sickness Durg Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Motion Sickness Durg, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Motion Sickness Durg, Product Offered and Application

3.8 Global Key Manufacturers of Motion Sickness Durg, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Motion Sickness Durg Sales by Type

4.1.1 Global Motion Sickness Durg Historical Sales by Type (2019-2024)

4.1.2 Global Motion Sickness Durg Forecasted Sales by Type (2025-2030)

4.1.3 Global Motion Sickness Durg Sales Market Share by Type (2019-2030)

4.2 Global Motion Sickness Durg Revenue by Type

4.2.1 Global Motion Sickness Durg Historical Revenue by Type (2019-2024)

4.2.2 Global Motion Sickness Durg Forecasted Revenue by Type (2025-2030)

4.2.3 Global Motion Sickness Durg Revenue Market Share by Type (2019-2030)

4.3 Global Motion Sickness Durg Price by Type

4.3.1 Global Motion Sickness Durg Price by Type (2019-2024)

4.3.2 Global Motion Sickness Durg Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Motion Sickness Durg Sales by Application

5.1.1 Global Motion Sickness Durg Historical Sales by Application (2019-2024)

5.1.2 Global Motion Sickness Durg Forecasted Sales by Application (2025-2030)

5.1.3 Global Motion Sickness Durg Sales Market Share by Application (2019-2030)

5.2 Global Motion Sickness Durg Revenue by Application

5.2.1 Global Motion Sickness Durg Historical Revenue by Application (2019-2024)

5.2.2 Global Motion Sickness Durg Forecasted Revenue by Application (2025-2030)

5.2.3 Global Motion Sickness Durg Revenue Market Share by Application (2019-2030)

5.3 Global Motion Sickness Durg Price by Application

5.3.1 Global Motion Sickness Durg Price by Application (2019-2024)

5.3.2 Global Motion Sickness Durg Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Motion Sickness Durg Market Size by Type

6.1.1 US & Canada Motion Sickness Durg Sales by Type (2019-2030)

6.1.2 US & Canada Motion Sickness Durg Revenue by Type (2019-2030)

6.2 US & Canada Motion Sickness Durg Market Size by Application

6.2.1 US & Canada Motion Sickness Durg Sales by Application (2019-2030)

6.2.2 US & Canada Motion Sickness Durg Revenue by Application (2019-2030)

6.3 US & Canada Motion Sickness Durg Market Size by Country

6.3.1 US & Canada Motion Sickness Durg Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Motion Sickness Durg Sales by Country (2019-2030)

6.3.3 US & Canada Motion Sickness Durg Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Motion Sickness Durg Market Size by Type

7.1.1 Europe Motion Sickness Durg Sales by Type (2019-2030)

7.1.2 Europe Motion Sickness Durg Revenue by Type (2019-2030)

7.2 Europe Motion Sickness Durg Market Size by Application

7.2.1 Europe Motion Sickness Durg Sales by Application (2019-2030)

7.2.2 Europe Motion Sickness Durg Revenue by Application (2019-2030)

7.3 Europe Motion Sickness Durg Market Size by Country

7.3.1 Europe Motion Sickness Durg Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Motion Sickness Durg Sales by Country (2019-2030)

7.3.3 Europe Motion Sickness Durg Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Motion Sickness Durg Market Size

8.1.1 China Motion Sickness Durg Sales (2019-2030)

8.1.2 China Motion Sickness Durg Revenue (2019-2030)

8.2 China Motion Sickness Durg Market Size by Application

8.2.1 China Motion Sickness Durg Sales by Application (2019-2030)

8.2.2 China Motion Sickness Durg Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Motion Sickness Durg Market Size by Type

9.1.1 Asia Motion Sickness Durg Sales by Type (2019-2030)

9.1.2 Asia Motion Sickness Durg Revenue by Type (2019-2030)

9.2 Asia Motion Sickness Durg Market Size by Application

9.2.1 Asia Motion Sickness Durg Sales by Application (2019-2030)

9.2.2 Asia Motion Sickness Durg Revenue by Application (2019-2030)

9.3 Asia Motion Sickness Durg Sales by Region

9.3.1 Asia Motion Sickness Durg Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Motion Sickness Durg Revenue by Region (2019-2030)

9.3.3 Asia Motion Sickness Durg Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Motion Sickness Durg Market Size by Type

10.1.1 Middle East, Africa and Latin America Motion Sickness Durg Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Motion Sickness Durg Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Motion Sickness Durg Market Size by Application

10.2.1 Middle East, Africa and Latin America Motion Sickness Durg Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Motion Sickness Durg Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Motion Sickness Durg Sales by Country

10.3.1 Middle East, Africa and Latin America Motion Sickness Durg Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Motion Sickness Durg Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Motion Sickness Durg Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Information

11.1.2 GlaxoSmithKline Overview

11.1.3 GlaxoSmithKline Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 GlaxoSmithKline Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 GlaxoSmithKline Recent Developments

11.2 Prestige Brands

11.2.1 Prestige Brands Company Information

11.2.2 Prestige Brands Overview

11.2.3 Prestige Brands Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Prestige Brands Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Prestige Brands Recent Developments

11.3 WellSpring Pharmaceutical Corporation

11.3.1 WellSpring Pharmaceutical Corporation Company Information

11.3.2 WellSpring Pharmaceutical Corporation Overview

11.3.3 WellSpring Pharmaceutical Corporation Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 WellSpring Pharmaceutical Corporation Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 WellSpring Pharmaceutical Corporation Recent Developments

11.4 Baxter International

11.4.1 Baxter International Company Information

11.4.2 Baxter International Overview

11.4.3 Baxter International Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Baxter International Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Baxter International Recent Developments

11.5 Mylan

11.5.1 Mylan Company Information

11.5.2 Mylan Overview

11.5.3 Mylan Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Mylan Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Mylan Recent Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis Overview

11.6.3 Novartis Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Novartis Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Novartis Recent Developments

11.7 Pfizer

11.7.1 Pfizer Company Information

11.7.2 Pfizer Overview

11.7.3 Pfizer Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Pfizer Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Pfizer Recent Developments

11.8 Myungmoon Pharm

11.8.1 Myungmoon Pharm Company Information

11.8.2 Myungmoon Pharm Overview

11.8.3 Myungmoon Pharm Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Myungmoon Pharm Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Myungmoon Pharm Recent Developments

11.9 Caleb Pharmaceuticals

11.9.1 Caleb Pharmaceuticals Company Information

11.9.2 Caleb Pharmaceuticals Overview

11.9.3 Caleb Pharmaceuticals Motion Sickness Durg Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Caleb Pharmaceuticals Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Caleb Pharmaceuticals Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Motion Sickness Durg Industry Chain Analysis

12.2 Motion Sickness Durg Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Motion Sickness Durg Production Mode & Process

12.4 Motion Sickness Durg Sales and Marketing

12.4.1 Motion Sickness Durg Sales Channels

12.4.2 Motion Sickness Durg Distributors

12.5 Motion Sickness Durg Customers

13 Market Dynamics

13.1 Motion Sickness Durg Industry Trends

13.2 Motion Sickness Durg Market Drivers

13.3 Motion Sickness Durg Market Challenges

13.4 Motion Sickness Durg Market Restraints

14 Key Findings in The Global Motion Sickness Durg Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Prestige Brands

WellSpring Pharmaceutical Corporation

Caleb Pharmaceuticals

Novartis

List of Tables

Table 1. Global Motion Sickness Durg Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Anticholinergic

Table 3. Major Manufacturers of Antihistamines

Table 4. Major Manufacturers of Others

Table 5. Global Motion Sickness Durg Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Motion Sickness Durg Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Motion Sickness Durg Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Motion Sickness Durg Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Motion Sickness Durg Revenue Market Share by Region (2019-2024)

Table 10. Global Motion Sickness Durg Revenue Market Share by Region (2025-2030)

Table 11. Global Motion Sickness Durg Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Motion Sickness Durg Sales by Region (2019-2024) & (K Units)

Table 13. Global Motion Sickness Durg Sales by Region (2025-2030) & (K Units)

Table 14. Global Motion Sickness Durg Sales Market Share by Region (2019-2024)

Table 15. Global Motion Sickness Durg Sales Market Share by Region (2025-2030)

Table 16. Global Motion Sickness Durg Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global Motion Sickness Durg Sales Share by Manufacturers (2019-2024)

Table 18. Global Motion Sickness Durg Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Motion Sickness Durg Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Motion Sickness Durg, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Motion Sickness Durg Price by Manufacturers 2019-2024 (US$/Unit)

Table 22. Global Motion Sickness Durg Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Motion Sickness Durg by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Motion Sickness Durg as of 2023)

Table 24. Global Key Manufacturers of Motion Sickness Durg, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Motion Sickness Durg, Product Offered and Application

Table 26. Global Key Manufacturers of Motion Sickness Durg, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Motion Sickness Durg Sales by Type (2019-2024) & (K Units)

Table 29. Global Motion Sickness Durg Sales by Type (2025-2030) & (K Units)

Table 30. Global Motion Sickness Durg Sales Share by Type (2019-2024)

Table 31. Global Motion Sickness Durg Sales Share by Type (2025-2030)

Table 32. Global Motion Sickness Durg Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Motion Sickness Durg Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Motion Sickness Durg Revenue Share by Type (2019-2024)

Table 35. Global Motion Sickness Durg Revenue Share by Type (2025-2030)

Table 36. Motion Sickness Durg Price by Type (2019-2024) & (US$/Unit)

Table 37. Global Motion Sickness Durg Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global Motion Sickness Durg Sales by Application (2019-2024) & (K Units)

Table 39. Global Motion Sickness Durg Sales by Application (2025-2030) & (K Units)

Table 40. Global Motion Sickness Durg Sales Share by Application (2019-2024)

Table 41. Global Motion Sickness Durg Sales Share by Application (2025-2030)

Table 42. Global Motion Sickness Durg Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Motion Sickness Durg Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Motion Sickness Durg Revenue Share by Application (2019-2024)

Table 45. Global Motion Sickness Durg Revenue Share by Application (2025-2030)

Table 46. Motion Sickness Durg Price by Application (2019-2024) & (US$/Unit)

Table 47. Global Motion Sickness Durg Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada Motion Sickness Durg Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada Motion Sickness Durg Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada Motion Sickness Durg Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Motion Sickness Durg Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Motion Sickness Durg Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada Motion Sickness Durg Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada Motion Sickness Durg Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Motion Sickness Durg Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Motion Sickness Durg Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Motion Sickness Durg Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Motion Sickness Durg Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Motion Sickness Durg Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada Motion Sickness Durg Sales by Country (2025-2030) & (K Units)

Table 61. Europe Motion Sickness Durg Sales by Type (2019-2024) & (K Units)

Table 62. Europe Motion Sickness Durg Sales by Type (2025-2030) & (K Units)

Table 63. Europe Motion Sickness Durg Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Motion Sickness Durg Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Motion Sickness Durg Sales by Application (2019-2024) & (K Units)

Table 66. Europe Motion Sickness Durg Sales by Application (2025-2030) & (K Units)

Table 67. Europe Motion Sickness Durg Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Motion Sickness Durg Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Motion Sickness Durg Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Motion Sickness Durg Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Motion Sickness Durg Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Motion Sickness Durg Sales by Country (2019-2024) & (K Units)

Table 73. Europe Motion Sickness Durg Sales by Country (2025-2030) & (K Units)

Table 74. China Motion Sickness Durg Sales by Type (2019-2024) & (K Units)

Table 75. China Motion Sickness Durg Sales by Type (2025-2030) & (K Units)

Table 76. China Motion Sickness Durg Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Motion Sickness Durg Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Motion Sickness Durg Sales by Application (2019-2024) & (K Units)

Table 79. China Motion Sickness Durg Sales by Application (2025-2030) & (K Units)

Table 80. China Motion Sickness Durg Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Motion Sickness Durg Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Motion Sickness Durg Sales by Type (2019-2024) & (K Units)

Table 83. Asia Motion Sickness Durg Sales by Type (2025-2030) & (K Units)

Table 84. Asia Motion Sickness Durg Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Motion Sickness Durg Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Motion Sickness Durg Sales by Application (2019-2024) & (K Units)

Table 87. Asia Motion Sickness Durg Sales by Application (2025-2030) & (K Units)

Table 88. Asia Motion Sickness Durg Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Motion Sickness Durg Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Motion Sickness Durg Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Motion Sickness Durg Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Motion Sickness Durg Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Motion Sickness Durg Sales by Region (2019-2024) & (K Units)

Table 94. Asia Motion Sickness Durg Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America Motion Sickness Durg Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America Motion Sickness Durg Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Motion Sickness Durg Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Motion Sickness Durg Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Motion Sickness Durg Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America Motion Sickness Durg Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Motion Sickness Durg Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Motion Sickness Durg Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Motion Sickness Durg Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Motion Sickness Durg Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Motion Sickness Durg Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Motion Sickness Durg Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America Motion Sickness Durg Sales by Country (2025-2030) & (K Units)

Table 108. GlaxoSmithKline Company Information

Table 109. GlaxoSmithKline Description and Major Businesses

Table 110. GlaxoSmithKline Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. GlaxoSmithKline Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. GlaxoSmithKline Recent Developments

Table 113. Prestige Brands Company Information

Table 114. Prestige Brands Description and Major Businesses

Table 115. Prestige Brands Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. Prestige Brands Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Prestige Brands Recent Developments

Table 118. WellSpring Pharmaceutical Corporation Company Information

Table 119. WellSpring Pharmaceutical Corporation Description and Major Businesses

Table 120. WellSpring Pharmaceutical Corporation Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 121. WellSpring Pharmaceutical Corporation Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. WellSpring Pharmaceutical Corporation Recent Developments

Table 123. Baxter International Company Information

Table 124. Baxter International Description and Major Businesses

Table 125. Baxter International Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 126. Baxter International Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Baxter International Recent Developments

Table 128. Mylan Company Information

Table 129. Mylan Description and Major Businesses

Table 130. Mylan Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 131. Mylan Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Mylan Recent Developments

Table 133. Novartis Company Information

Table 134. Novartis Description and Major Businesses

Table 135. Novartis Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 136. Novartis Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Novartis Recent Developments

Table 138. Pfizer Company Information

Table 139. Pfizer Description and Major Businesses

Table 140. Pfizer Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 141. Pfizer Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Pfizer Recent Developments

Table 143. Myungmoon Pharm Company Information

Table 144. Myungmoon Pharm Description and Major Businesses

Table 145. Myungmoon Pharm Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 146. Myungmoon Pharm Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Myungmoon Pharm Recent Developments

Table 148. Caleb Pharmaceuticals Company Information

Table 149. Caleb Pharmaceuticals Description and Major Businesses

Table 150. Caleb Pharmaceuticals Motion Sickness Durg Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 151. Caleb Pharmaceuticals Motion Sickness Durg Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Caleb Pharmaceuticals Recent Developments

Table 153. Key Raw Materials Lists

Table 154. Raw Materials Key Suppliers Lists

Table 155. Motion Sickness Durg Distributors List

Table 156. Motion Sickness Durg Customers List

Table 157. Motion Sickness Durg Market Trends

Table 158. Motion Sickness Durg Market Drivers

Table 159. Motion Sickness Durg Market Challenges

Table 160. Motion Sickness Durg Market Restraints

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Motion Sickness Durg Product Picture

Figure 2. Global Motion Sickness Durg Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Motion Sickness Durg Market Share by Type in 2023 & 2030

Figure 4. Anticholinergic Product Picture

Figure 5. Antihistamines Product Picture

Figure 6. Others Product Picture

Figure 7. Global Motion Sickness Durg Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Motion Sickness Durg Market Share by Application in 2023 & 2030

Figure 9. Adults

Figure 10. Children

Figure 11. Motion Sickness Durg Report Years Considered

Figure 12. Global Motion Sickness Durg Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Motion Sickness Durg Revenue 2019-2030 (US$ Million)

Figure 14. Global Motion Sickness Durg Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Motion Sickness Durg Revenue Market Share by Region (2019-2030)

Figure 16. Global Motion Sickness Durg Sales 2019-2030 ((K Units)

Figure 17. Global Motion Sickness Durg Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Motion Sickness Durg Sales YoY (2019-2030) & (K Units)

Figure 19. US & Canada Motion Sickness Durg Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Motion Sickness Durg Sales YoY (2019-2030) & (K Units)

Figure 21. Europe Motion Sickness Durg Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Motion Sickness Durg Sales YoY (2019-2030) & (K Units)

Figure 23. China Motion Sickness Durg Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Motion Sickness Durg Sales YoY (2019-2030) & (K Units)

Figure 25. Asia (excluding China) Motion Sickness Durg Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Motion Sickness Durg Sales YoY (2019-2030) & (K Units)

Figure 27. Middle East, Africa and Latin America Motion Sickness Durg Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Motion Sickness Durg Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Motion Sickness Durg in the World: Market Share by Motion Sickness Durg Revenue in 2023

Figure 30. Global Motion Sickness Durg Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Motion Sickness Durg Sales Market Share by Type (2019-2030)

Figure 32. Global Motion Sickness Durg Revenue Market Share by Type (2019-2030)

Figure 33. Global Motion Sickness Durg Sales Market Share by Application (2019-2030)

Figure 34. Global Motion Sickness Durg Revenue Market Share by Application (2019-2030)

Figure 35. US & Canada Motion Sickness Durg Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Motion Sickness Durg Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Motion Sickness Durg Sales Market Share by Application (2019-2030)

Figure 38. US & Canada Motion Sickness Durg Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Motion Sickness Durg Revenue Share by Country (2019-2030)

Figure 40. US & Canada Motion Sickness Durg Sales Share by Country (2019-2030)

Figure 41. U.S. Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Motion Sickness Durg Sales Market Share by Type (2019-2030)

Figure 44. Europe Motion Sickness Durg Revenue Market Share by Type (2019-2030)

Figure 45. Europe Motion Sickness Durg Sales Market Share by Application (2019-2030)

Figure 46. Europe Motion Sickness Durg Revenue Market Share by Application (2019-2030)

Figure 47. Europe Motion Sickness Durg Revenue Share by Country (2019-2030)

Figure 48. Europe Motion Sickness Durg Sales Share by Country (2019-2030)

Figure 49. Germany Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 50. France Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 51. U.K. Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 52. Italy Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 53. Russia Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 54. China Motion Sickness Durg Sales Market Share by Type (2019-2030)

Figure 55. China Motion Sickness Durg Revenue Market Share by Type (2019-2030)

Figure 56. China Motion Sickness Durg Sales Market Share by Application (2019-2030)

Figure 57. China Motion Sickness Durg Revenue Market Share by Application (2019-2030)

Figure 58. Asia Motion Sickness Durg Sales Market Share by Type (2019-2030)

Figure 59. Asia Motion Sickness Durg Revenue Market Share by Type (2019-2030)

Figure 60. Asia Motion Sickness Durg Sales Market Share by Application (2019-2030)

Figure 61. Asia Motion Sickness Durg Revenue Market Share by Application (2019-2030)

Figure 62. Asia Motion Sickness Durg Revenue Share by Region (2019-2030)

Figure 63. Asia Motion Sickness Durg Sales Share by Region (2019-2030)

Figure 64. Japan Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 65. South Korea Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 66. China Taiwan Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 67. Southeast Asia Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 68. India Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Motion Sickness Durg Sales Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Motion Sickness Durg Revenue Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Motion Sickness Durg Sales Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Motion Sickness Durg Revenue Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Motion Sickness Durg Revenue Share by Country (2019-2030)

Figure 74. Middle East, Africa and Latin America Motion Sickness Durg Sales Share by Country (2019-2030)

Figure 75. Brazil Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 76. Mexico Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 77. Turkey Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 78. Israel Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 79. GCC Countries Motion Sickness Durg Revenue (2019-2030) & (US$ Million)

Figure 80. Motion Sickness Durg Value Chain

Figure 81. Motion Sickness Durg Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Motion Sickness Patch Market

Global Wearable Anti motion Sickness Bracelet Market Research Report 2024

Global Household Wearable Anti motion Sickness Bracelet Market Research Report 2024

Global Desynchronosis Treatment Market Insights Forecast to 2030

Jet Lag Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Wearable Anti motion Sickness Bracelet Market Research Report 2024

Global Jet Lag Treatment Market Insights Forecast to 2030

Global Seasickness Medicine Market Insights Forecast to 2030

Global Airsickness Treatment Market Insights Forecast to 2030

Global Travel Sickness Drugs Market Insights Forecast to 2030

Global Antihistamines Travel Sickness Drugs Market Insights Forecast to 2030

Global Anticholinergic Travel Sickness Drugs Market Insights Forecast to 2030

Global Kinetosis Drugs Market Insights Forecast to 2030

Global Air Sickness Bags Market Insights Forecast to 2030

Motion Sickness Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Scopolamine Market Insights Forecast to 2030

Global Time Zone Change Syndrome Treatment Market Insights Forecast to 2030

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Global Wearable Anti seasickness Bracelet Market Research Report 2024

RELATED REPORTS

Global Liposomal Doxorubicin Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39C8806

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Botox Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-0E9275

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Herbal Medicine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-25Y8773

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Dermatology OTC Medications Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19E9062

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions